Hits： Datetime：2020-07-11
NEW
YORK, June 5, 2019 /PRNewswire/ -- The analyst has compiled a study
on the pharmaceutical intermediates market, which offers an analysis and
forecast of the Pharmaceutical Intermediates market in its publication titled
'Pharmaceutical Intermediates Market: Global Industry Analysis 2014 – 2018 and
Opportunity Assessment 2019 – 2029.' This report on the Pharmaceutical
intermediates market covers some of the key influencing factors on the demand
and supply of Pharmaceutical Intermediates over the next several years. An
in-depth review of the growth drivers, potential challenges, unique trends, and
opportunities for the market participants is expected to equip readers to fully
comprehend the overall landscape of the Pharmaceutical Intermediates market.
Read the full
report: https://www.reportlinker.com/p05781370/?utm_source=PRN
The report on the
pharmaceutical intermediates market also covers an analysis of the key regions
and countries of particular interest, which are estimated to become
frontrunners or remain laggards over the forecast period. The report covers a
historical analysis of the market from 2014 to 2018, and provides forecasts
from 2019 to 2029 in terms of revenue in US$.
Pharmaceutical
intermediates are the raw materials used to manufacture active pharmaceutical
ingredients for the final drug formulation. There are different types of
pharmaceutical intermediates and demand of each type of the pharmaceutical
intermediates is high due to increasing pharmaceutical and biopharmaceutical
production.
This report on the
pharmaceutical intermediates market has been broken down into different
chapters to enhance clarity and provide context. A brief executive summary at
the beginning of the report consists of some of the key findings of the study
on the pharmaceutical intermediates market, as well as market estimates and
growth rates for important segments. The following chapter presents the
definitions and scope of the study, as well as the coverage in terms of the way
in which the pharmaceutical intermediates market is structured.
Subsequently, the
chapter on the market background contains relevant economic indicators, such as
per capita healthcare spending and increase in cancer cases, which elaborate
the dynamics impacting the pharmaceutical intermediates market, as well as
provides an explanation of the factors considered important to develop
forecasts and estimates. The following chapters dive deep into the global
pharmaceutical intermediates market, covering detailed information based on
product type, application and end user. The next set of chapters provide a
region-wise analysis and forecasts of the pharmaceutical intermediates market,
which cover the vital aspects of the market in North America, Latin
America, Europe, East Asia, South Asia, Oceania, and
the Middle East and Africa.
A dashboard view
of some of the key companies operating in the pharmaceutical intermediates
market in terms of their offerings, regional presence, and other metrics is a
precursor to the detailed profiles of these participants, which include their
financial information, strategy overview, and products offered, SWOT analysis
as well as analyst commentary. Some of the key players analyzed in the
Pharmaceutical Intermediates market report include Chiracon GmbH, Aceto
Corporation, Midas Pharma GmbH, BASF SE, Codexis, Inc., A.R. Life Sciences
Private Limited, Dishman Group, ZCL Chemicals Ltd., Pfizer, Inc., Arkema Inc
and Cambrex Corporation among others.
To develop the
estimates for the pharmaceutical intermediates market, the global
adoption/consumption of pharmaceutical intermediates was taken into account,
which was followed by tracking key players and their product offering globally.
This is then cross-referenced with the revenue generated from the sales of
pharmaceutical intermediates for top companies globally.
Our team of
analysts reviews and interpret data from a variety of sources. The data
attributed to 'FMI' is derived by using a combination of various approaches,
which are then consolidated, interpreted, and extrapolated by analysts. Data is
sourced from government statistics, trade associations, company annual reports,
investor presentations, press articles & directories, technical
publications, and online databases, which are cross-referenced with FMI's
reports and internal repository of data to filter and validate the collected
information.
The intelligence
gathered from desk research is supplemented by extensive interviews with
selected key expert participants across the value chain not only to gain
information specific to their role and operations, but also to obtain their
perspective and insights of the issues impacting the pharmaceutical
intermediates market.
Prev：No Prev
Please input keywords
Confirm
